HIV-1 tat-mediated induction of platelet-derived growth factor in astrocytes: Role of early growth response gene 1

Journal of Immunology

Volumn 186, Issue 7, 2011, Pages 4119-4129

  Bethel Brown, Crystal ^a   Yao, Honghong ^b   Callen, Shannon ^b   Lee, Young Han ^c   Dash, Prasanta K ^b   Kumar, Anil ^d   Buch, Shilpa ^b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c Konkuk University   (South Korea)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BB; STRESS ACTIVATED PROTEIN KINASE; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ASTROCYTES; CELL LINE, TUMOR; CELL PROLIFERATION; EARLY GROWTH RESPONSE PROTEIN 1; HIV-1; HUMANS; INFLAMMATION MEDIATORS; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; UP-REGULATION;

EID: 79954992762     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002235     Document Type: Article

References (52)

1. Kaul, M., and S. A. Lipton. 2006. Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr. HIV Res. 4: 307-318. (Pubitemid 44027720)
2. Gilgun-Sherki, Y., E. Melamed, and D. Offen. 2001. Oxidative stress inducedneurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 40: 959-975. (Pubitemid 32530602)
3. Ozdener, H. 2005. Molecular mechanisms of HIV-1 associated neurodegeneration. J. Biosci. 30: 391-405. (Pubitemid 40992220)
4. Giunta, B., D. Obregon, H. Hou, J. Zeng, N. Sun, V. Nikolic, J. Ehrhart, D. Shytle, F. Fernandez, and J. Tan. 2006. EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia. Brain Res. 1123: 216-225. (Pubitemid 44794387)
5. Albright, A. V., S. S. Soldan, and F. González-Scarano. 2003. Pathogenesis of human immunodeficiency virus-induced neurological disease. J. Neurovirol. 9: 222-227. (Pubitemid 36656455)
6. Navia, B. A., E. S. Cho, C. K. Petito, and R. W. Price. 1986. The AIDS dementia complex: II. Neuropathology. Ann. Neurol. 19: 525-535.
7. Fawcett, J. W., and R. A. Asher. 1999. The glial scar and central nervous system repair. Brain Res. Bull. 49: 377-391. (Pubitemid 29385505)
8. van Marle, G., S. Henry, T. Todoruk, A. Sullivan, C. Silva, S. B. Rourke, J. Holden, J. C. McArthur, M. J. Gill, and C. Power. 2004. Human immunodeficiency virus type 1 Nef protein mediates neural cell death: A neurotoxic role for IP-10. Virology 329: 302-318. (Pubitemid 39423980)
9. Kutsch, O., J. Oh, A. Nath, and E. N. Benveniste. 2000. Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J. Virol. 74: 9214-9221.
10. Potula, R., N. Dhillion, Y. Sui, C. A. Zien, K. Funa, D. Pinson, M. S. Mayo, D. K. Singh, O. Narayan, and S. Buch. 2004. Association of platelet-derived growth factor-B chain with simian human immunodeficiency virus encephalitis. Am. J. Pathol. 165: 815-824. (Pubitemid 39129289)
11. Andrae, J., R. Gallini, and C. Betsholtz. 2008. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 22: 1276-1312. (Pubitemid 351717519)
12. Seifert, R. A., C. E. Hart, P. E. Phillips, J. W. Forstrom, R. Ross, M. J. Murray, and D. F. Bowen-Pope. 1989. Two different subunits associate to create isoformspecific platelet-derived growth factor receptors. J. Biol. Chem. 264: 8771-8778. (Pubitemid 19151598)
13. Brown, R. L., M. P. Breeden, and D. G. Greenhalgh. 1994. PDGF and TGF-alpha act synergistically to improve wound healing in the genetically diabetic mouse. J. Surg. Res. 56: 562-570. (Pubitemid 24222406)
14. Lepistö, J., H. Kujari, J. Niinikoski, and M. Laato. 1994. Effects of heterodimeric isoform of platelet-derived growth factor PDGF-AB on wound healing in the rat. Eur. Surg. Res. 26: 267-272. (Pubitemid 24301885)
15. Graham, S., A. Leonidou, M. Lester, M. Heliotis, A. Mantalaris, and E. Tsiridis. 2009. Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing. Expert Opin. Investig. Drugs 18: 1633-1654.
16. Stürzl, M., W. K. Roth, N. H. Brockmeyer, C. Zietz, B. Speiser, and P. H. Hofschneider. 1992. Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. Proc. Natl. Acad. Sci. USA 89: 7046-7050.
17. Cao,Y., R.Cao, and E. M. Hedlund. 2008. R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways. J. Mol. Med. 86: 785-789.
18. Claesson-Welsh, L. 1996. Mechanism of action of platelet-derived growth factor. Int. J. Biochem. Cell Biol. 28: 373-385. (Pubitemid 26141379)
19. Hede, S. M., I. Hansson, G. B. Afink, A. Eriksson, I. Nazarenko, J. Andrae, G. Genove, B. Westermark, and M. Nistér. 2009. GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background. Glia 57: 1143-1153.
20. Nunnari, G., J. A. Smith, and R. Daniel. 2008. HIV-1 Tat and AIDS-associated cancer: targeting the cellular anti-cancer barrier? J. Exp. Clin. Cancer Res. 27: 3.
21. Su, E. J., L. Fredriksson, M. Geyer, E. Folestad, J. Cale, J. Andrae, Y. Gao, K. Pietras, K. Mann, M. Yepes, et al. 2008. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat. Med. 14: 731-737.
22. Yao, H., J. E. Allen, X. Zhu, S. Callen, and S. Buch. 2009. Cocaine and human immunodeficiency virus type 1 gp120 mediate neurotoxicity through overlapping signaling pathways. J. Neurovirol. 15: 164-175.
23. Yao, H., F. Peng, N. Dhillon, S. Callen, S. Bokhari, L. Stehno-Bittel, S. O. Ahmad, J. Q. Wang, and S. Buch. 2009. Involvement of TRPC channels in CCL2-mediated neuroprotection against tat toxicity. J. Neurosci. 29: 1657-1669.
24. Turchan, J., C. Anderson, K. F. Hauser, Q. Sun, J. Zhang, Y. Liu, P. M. Wise, I. Kruman, W. Maragos, M. P. Mattson, et al. 2001. Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC Neurosci. 2: 3.
25. Hollman, A. M., D. A. Christian, P. D. Ray, D. Galey, J. Turchan, A. Nath, and D. Bhattacharyya. 2005. Selective isolation and purification of tat protein via affinity membrane separation. Biotechnol. Prog. 21: 451-459. (Pubitemid 40473709)
26. Ma, M., and A. Nath. 1997. Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J. Virol. 71: 2495-2499. (Pubitemid 27078635)
27. Westendorp, M. O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H.Walczak, K. M. Debatin, and P. H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375: 497-500.
28. Bonavia, R., A. Bajetto, S. Barbero, A. Albini, D. M. Noonan, and G. Schettini. 2001. HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. Biochem. Biophys. Res. Commun. 288: 301-308. (Pubitemid 33022484)
29. Hayashi, K., H. Pu, I. E. Andras, S. Y. Eum, A. Yamauchi, B. Hennig, and M. Toborek. 2006. HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier. J. Cereb. Blood Flow Metab. 26: 1052-1065. (Pubitemid 44134076)
30. Oshima, T., S. C. Flores, G. Vaitaitis, L. L. Coe, T. Joh, J. H. Park, Y. Zhu, B. Alexander, and J. S. Alexander. 2000. HIV-1 Tat increases endothelial solute permeability through tyrosine kinase and mitogen-activated protein kinasedependent pathways. AIDS 14: 475-482. (Pubitemid 30209689)
31. Prendergast, M. A., D. T. Rogers, P. J. Mulholland, J. M. Littleton, L. H. Wilkins, Jr., R. L. Self, and A. Nath. 2002. Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-D-aspartate receptor. Brain Res. 954: 300-307. (Pubitemid 35284670)
32. Speth, C., T. Schabetsberger, I. Mohsenipour, G. Stöckl, R. Würzner, H. Stoiber, C. Lass-Flörl, and M. P. Dierich. 2002. Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. J. Virol. 76: 3179-3188. (Pubitemid 34224519)
33. Gorantla, S., K. Santos, V. Meyer, S. Dewhurst, W. J. Bowers, H. J. Federoff, H. E. Gendelman, and L. Poluektova. 2005. Human dendritic cells transduced with herpes simplex virus amplicons encoding human immunodeficiency virus type 1 (HIV-1) gp120 elicit adaptive immune responses from human cells engrafted into NOD/SCID mice and confer partial protection against HIV-1 challenge. J. Virol. 79: 2124-2132. (Pubitemid 40204570)
34. Bezzi, P., M. Domercq, L. Brambilla, R. Galli, D. Schols, E. De Clercq, A. Vescovi, G. Bagetta, G. Kollias, J. Meldolesi, and A. Volterra. 2001. CXCR4-activated astrocyte glutamate release via TNFalpha: Amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4: 702-710. (Pubitemid 32595408)
35. Kaul, M., G. A. Garden, and S. A. Lipton. 2001. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410: 988-994. (Pubitemid 32335850)
36. Davis, R. L., J. Dertien, and P. J. Syapin. 2002. Ethanol-induced modulation of inducible nitric-oxide synthase activity in human A172 astrocytoma cells. Alcohol. Clin. Exp. Res. 26: 1404-1411.
37. Khachigian, L. M., V. Lindner, A. J. Williams, and T. Collins. 1996. Egr-1-induced endothelial gene expression: A common theme in vascular injury. Science 271: 1427-1431. (Pubitemid 26089480)
38. Dhillon, N. K., F. Peng, R. M. Ransohoff, and S. Buch. 2007. PDGF synergistically enhances IFN-gamma-induced expression of CXCL10 in bloodderived macrophages: implications for HIV dementia. J. Immunol. 179: 2722-2730.
39. Luo, J., and M. W. Miller. 1999. Platelet-derived growth factor-mediated signal transduction underlying astrocyte proliferation: site of ethanol action. J. Neurosci. 19: 10014-10025. (Pubitemid 30226673)
40. Zhou, B. Y., Y. Liu, B. Kim, Y. Xiao, and J. J. He. 2004. Astrocyte activation and dysfunction and neuron death by HIV-1 Tat expression in astrocytes. Mol. Cell. Neurosci. 27: 296-305. (Pubitemid 39439968)
41. James, A. B., A. M. Conway, and B. J. Morris. 2005. Genomic profiling of the neuronal target genes of the plasticity-related transcription factor-Zif268. J. Neurochem. 95: 796-810. (Pubitemid 41567171)
42. Silverman, E. S., and T. Collins. 1999. Pathways of Egr-1-mediated gene transcription in vascular biology. Am. J. Pathol. 154: 665-670. (Pubitemid 29122584)
43. Peng, F., H. Yao, X. Bai, X. Zhu, B. C. Reiner, M. Beazely, K. Funa, H. Xiong, and S. Buch. 2010. Platelet-derived growth factor-mediated induction of the synaptic plasticity gene Arc/Arg3.1. J. Biol. Chem. 285: 21615-21624.
44. Shin, H. J., J. B. Lee, S. H. Park, J. Chang, and C.W. Lee. 2009. T-bet expression is regulated by EGR1-mediated signaling in activated T cells. Clin. Immunol. 131: 385-394.
45. Freter, R. R., J. A. Alberta, G. Y. Hwang, A. L. Wrentmore, and C. D. Stiles. 1996. Platelet-derived growth factor induction of the immediate-early gene MCP-1 is mediated by NF-kappaB and a 90-kDa phosphoprotein coactivator. J. Biol. Chem. 271: 17417-17424. (Pubitemid 26244306)
46. Poon, M., W. C. Hsu, V. Y. Bogdanov, and M. B. Taubman. 1996. Secretion of monocyte chemotactic activity by cultured rat aortic smooth muscle cells in response to PDGF is due predominantly to the induction of JE/MCP-1. Am. J. Pathol. 149: 307-317. (Pubitemid 26231001)
47. Eugenin, E. A., K. Osiecki, L. Lopez, H. Goldstein, T. M. Calderon, and J. W. Berman. 2006. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: A potential mechanism of HIV-CNS invasion and NeuroAIDS. J. Neurosci. 26: 1098-1106. (Pubitemid 43237041)
48. Dhillon, N. K., R. Williams, S. Callen, C. Zien, O. Narayan, and S. Buch. 2008. Roles of MCP-1 in development of HIV-dementia. Front. Biosci. 13: 3913-3918. (Pubitemid 351594669)
49. Conant, K., A. Garzino-Demo, A. Nath, J. C. McArthur, W. Halliday, C. Power, R. C. Gallo, and E. O. Major. 1998. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc. Natl. Acad. Sci. USA 95: 3117-3121. (Pubitemid 28135864)
50. Sanders,V. J., C. A. Pittman, M. G. White, G.Wang, C. A.Wiley, and C. L. Achim. 1998. Chemokines and receptors in HIV encephalitis. AIDS 12: 1021-1026. (Pubitemid 28276969)
51. Bell, J. E. 1998. The neuropathology of adult HIV infection. Rev. Neurol. (Paris) 154: 816-829. (Pubitemid 29042415)
52. Fan, Y., W. Zou, L. A. Green, B. O. Kim, and J. J. He. 2011. Activation of Egr-1 expression in astrocytes by HIV-1 Tat: New Insights into astrocyte-mediated Tat neurotoxicity. J. Neuroimmune Pharmacol. 6: 121-129.